无新生血管性年龄相关性黄斑变性伴视网膜下液:形态与长期结局
回顾性研究纳入45眼无黄斑新生血管(MNV)的年龄相关性黄斑变性(AMD)伴视网膜下液(SRF)患眼,平均随访49.7±36.7个月。SRF呈现三种形态,60%患眼出现玻璃膜疣或玻璃膜疣性色素上皮脱离塌陷,53%发展为完全或不完全性视网膜色素上皮和 outer retinal 萎缩。结论提示识别此类SRF可避免不必要的抗VEGF治疗。
要点
- 无MNV的AMD患眼可出现SRF,需与新生血管性AMD鉴别以免误用抗VEGF治疗。
- SRF可表现为玻璃膜疣顶部液体帽、玻璃膜疣间隙液体袋或融合玻璃膜疣表面低平液体披覆。
- 随访中常见玻璃膜疣/玻璃膜疣性PED塌陷及视网膜色素上皮和 outer retinal 萎缩进展。
核心结论
- 无新生血管性AMD伴SRF是重要临床实体,识别后可避免不必要的抗血管内皮生长因子治疗。
- SRF可能与玻璃膜疣或玻璃膜疣性PED相关,且无MNV,可能源于视网膜色素上皮代偿失调和泵功能衰竭。
研究设计与样本
- 回顾性研究仅纳入无新生血管性AMD伴SRF的患眼,排除有MNV证据的眼。
- 基线和随访时行谱域光学相干断层扫描(SD-OCT),对黄斑玻璃膜疣包括玻璃膜疣性PED及相关SRF进行定性和定量分析以确定解剖结局。
- 共纳入45眼(45例患者),平均随访49.7±36.7个月。
主要发现
- SRF呈现三种不同形态:玻璃膜疣性PED顶点之上的液体帽、大玻璃膜疣角度或融合玻璃膜疣隐窝处的液体袋、融合玻璃膜疣上方低平液体的披覆。
- 45眼中有24眼(53%)出现完全或不完全性视网膜色素上皮和 outer retinal 萎缩的证据。
关键数值与推荐
- SRF三种形态:玻璃膜疣性PED顶点之上的液体帽;大玻璃膜疣角度或融合玻璃膜疣隐窝处的液体袋;融合玻璃膜疣上方低平液体的披覆。
- 45眼中24眼(53%)出现完全或不完全性视网膜色素上皮和 outer retinal 萎缩。
临床怎么用
- 对AMD伴SRF但无MNV证据的患眼,应识别其SRF形态以避免不必要的抗VEGF治疗。
- 随访中关注玻璃膜疣/玻璃膜疣性PED塌陷及视网膜色素上皮和 outer retinal 萎缩的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the various patterns of subretinal fluid (SRF) in eyes with age-related macular degeneration (AMD) in the absence of macular neovascularisation (MNV) and to assess the long-term outcomes in these eyes. METHODS: This retrospective study included only eyes with non-neovascular AMD and associated SRF. Eyes with evidence of MNV were excluded. Spectral-domain optical coherence tomography (SD-OCT) was obtained at baseline and at follow-up, and qualitative and quantitative SD-OCT analysis of macular drusen including drusenoid pigment epithelial detachment (PED) and associated SRF was performed to determine anatomic outcomes. RESULTS: Forty-five eyes (45 patients) were included in this analysis. Mean duration of follow-up was 49.7±36.7 months. SRF exhibited three different morphologies: crest of fluid over the apex of the drusenoid PED, pocket of fluid at the angle of a large druse or in the crypt of confluent drusen or drape of low-lying fluid over confluent drusen. Twenty-seven (60%) of the 45 eyes with fluid displayed collapse of the associated druse or drusenoid PED and 24 (53%) of the 45 eyes developed evidence of complete or incomplete retinal pigment epithelial and outer retinal atrophy. CONCLUSION: Non-neovascular AMD with SRF is an important clinical entity to recognise to avoid unnecessary anti-vascular endothelial growth factor therapy. Clinicians should be aware that SRF can be associated with drusen or drusenoid PED in the absence of MNV and may be the result of retinal pigment epithelial (RPE) decompensation and RPE pump failure.
引用
- Hilely A, Au A, Freund KB, et al. Non-neovascular age-related macular degeneration with subretinal fluid. Br J Ophthalmol. 2020. PMID: 32920528. doi:10.1136/bjophthalmol-2020-317326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。